New York, April 09, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "COVID-19: Analysis of the Emerging Disease Landscape - March 2020" - https://www.reportlinker.com/p05881500/?utm_source=GNW
A range of players - from pharma and biotech firms to academic institutions and government agencies - have thrown their hats in the ring.
Scope
- Global epidemiology metrics and trends
- Snapshot of epidemiological trends to date in the top three most-affected countries
- An overview of the pipeline for antivirals and vaccines
- Summary of available efficacy data
- An assessment of the clinical trials landscape by phase, sponsor type, geography, and other key attributes
- Highlights in deal-making trends, particularly public-private partnerships
- Spotlight on social media coverage
Reasons to Buy
- Global epidemiology metrics and trends
- Snapshot of epidemiological trends to date in the top three most-affected countries
- An overview of the pipeline for antivirals and vaccines
- Summary of available efficacy data
- An assessment of the clinical trials landscape by phase, sponsor type, geography, and other key attributes
- Highlights in deal-making trends, particularly public-private partnerships
- Spotlight on social media coverage
Read the full report: https://www.reportlinker.com/p05881500/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
COVID-19: Analysis of the Emerging Disease Landscape - March 2020
Summary The epidemiology of COVID-19 is rapidly evolving and a number of companies have begun to invest in this space. The absence of proven therapeutic options and the lack of a vaccine to protect against infection has led to a race to develop effective interventions.
| Source: ReportLinker